Chembio Diagnostics Inc
Diagnostics & Research
Healthcare
CEMI
20.10M shares
NASDAQ US
traded
28 Dec 2021
open
1.70
52 week high
7.97
high
1.70
52 week low
1.56
low
1.55
growth
-69.41%
previous Close
1.67
P/E ratio
-7
market cap
58.39M
div yield
0
usd
Sep 2021
qoq
revenue
12.06M
86.60 %
net incoming
-6.37M
29.77 %
eps
-0.24
46.67 %
eps surprise
-26.32 %
net profit margin
-52.79 %
87.00 %
operating incoming
-5.63M
32.46 %
net change in cash
30.44M
346,556.31 %
cash on hand
36.00M
547.05 %
cost of revenue
7.90M
95.63 %
top top